SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Ionis Pharmaceuticals (IONS)
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
4676 121 0 IONS
Emcee:  Keith Fauci Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
4076comment from forbes at end of story about dendreon disaster.. "...All is nbob zagorin-5/9/2007
4075Bristol-Myers Squibb Enters Cardiovascular Disease Collaboration With Isis Pharmkenhott-5/9/2007
4074pubs.acs.org >>May 7, 2007 Volume 85, Number 19 p. 32 Funding Strategiebob zagorin-5/8/2007
4073Webcast Alert: Isis Pharmaceuticals Announces First Quarter 2007 Financial Resulbob zagorin-5/3/2007
4072Bob--Thanks for keeping everybody up to date on ISIS. Isis will break out strongJOEBT1-5/2/2007
4071Bruker link to pdf on Ibis biosensor: bdal.combob zagorin-5/2/2007
4070repost from IV isis board: Future meeting - June 10 - 13 - EAS 76th Congress - bob zagorin-4/23/2007
4069repost from yhoo board... FASEB - EXPERIMENTAL BIOLOGY ANNUAL MEETING, April 28bob zagorin-4/21/2007
4068big anitsense rnai conference with lots of speakers from isis alny avii et. al..bob zagorin-4/20/2007
4067from yahoo board.. Presentations at AACR this weekend by ISIS: Presentation Tibob zagorin-4/13/2007
4066Isis Pharmaceuticals, Inc. 5 ½% Convertible Subordinated Notes due 2009 bob zagorin-4/12/2007
4065ir.isispharm.combob zagorin-4/11/2007
4064Novosom AG Acquires Exclusive Option for CD40-Targeted Antisense Inhibitors Frombob zagorin-4/11/2007
4063Presentation Title: Targeting the protein translation factor eIF4E for cancer tbob zagorin-4/11/2007
4062link for annual meeting proxy isis.client.shareholder.combob zagorin-4/10/2007
4061<ISIS 301012 seems a lot safer than the MTP inhibitors> That is ISIS'kenhott-4/10/2007
4060[Isis 301012: Antisense Apo B-100 in HCV therapy?] >>Proc Natl Acad Sci Utuck-4/9/2007
4059here's a link for summer street research with a little bio on the analyst...bob zagorin-4/4/2007
4058Isis Pharmaceuticals Rated New `Buy' at Summer Street :ISIS US By Sybil Chabob zagorin-4/4/2007
4057another presentation upcoming ir.isispharm.combob zagorin-4/4/2007
4056from IV board - a thoughtful post imo on why ISIS second gen. drugs work better bob zagorin-4/3/2007
4055Cholesterol Remains a Sticky Foe By Robert Steyer TheStreet.com Staff Reporter 3bob zagorin-4/1/2007
4054short interest increased 37% as of march reporting date (3/15 i think) ISIS bob zagorin-3/30/2007
4053on the broader topic of pfizer's failure and statin problems..(dont own ant bob zagorin-3/30/2007
4052that's probably true dew. i'm betting they will have a partner soon... tbob zagorin-3/28/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News